Skip to content

Clinical trials

Phase 1/2 Graves Ophthalmopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Ophthalmopathy Phase: Phase 1/2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20111
20121
20221
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Not yet recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ACELYRIN Inc.1
Amgen1
Kriya Therapeutics, Inc.1
Lassen Therapeutics 1 PTY LTD1
Nanjing Chia-tai Tianqing Pharmaceutical1
Odense University Hospital1
Rabin Medical Center1
Silkiss, Rona Z., M.D., FACS1
Sun Yat-sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Ophthalmopathy9
Graves Disease3
Autoimmune Diseases2
Eye Diseases2
Thyroid Diseases2
Endocrine System Diseases1
Eye Diseases, Hereditary1
Hyperthyroidism1
Immune System Diseases1
Inflammation1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.